We are live on
!
Find out more
OLA
Oliver Luxxe Assets Portfolio holdings
AUM
$680M
1-Year Est. Return
47.51%
This Fund
S&P 500
This Quarter
Est. Return
+0.23%
1 Year Est. Return
+47.51%
3 Year Est. Return
+141.35%
5 Year Est. Return
+220.75%
10 Year Est. Return
+625.72%
AUM
$395M
AUM Growth
+$211K
(+0.05%)
Cap. Flow
+$9.86M
Cap. Flow
% of AUM
2.5%
Top 10 Holdings %
Top 10 Hldgs %
21.55%
Holding
226
New
31
Increased
81
Reduced
53
Closed
36
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baker Hughes
BKR
|
+$5.7M |
| 2 |
Procter & Gamble
PG
|
+$4.59M |
| 3 |
Becton Dickinson
BDX
|
+$4.44M |
| 4 |
McKesson
MCK
|
+$4.33M |
| 5 |
WBA
Walgreens Boots Alliance
WBA
|
+$4.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$4.63M |
| 2 |
Lam Research
LRCX
|
+$3.63M |
| 3 |
Blackstone
BX
|
+$3.35M |
| 4 |
TJX Companies
TJX
|
+$3.3M |
| 5 |
TE Connectivity
TEL
|
+$3.19M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 16.84% |
| 2 | Financials | 13.99% |
| 3 | Healthcare | 12.69% |
| 4 | Energy | 9.97% |
| 5 | Technology | 6.98% |
Similar funds
CCG
CIA
NS
WDL
HI
ISWM
TIP
AP
Oliver Luxxe Assets's Q1 2022 Portfolio in Review
As of Q1 2022, Oliver Luxxe Assets held 226 positions worth $395M, up 0.05% from $395M the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Oliver Luxxe Assets's Q1 2022 filing shows 31 new, 81 increased, 53 reduced and 36 closed positions. Its largest new stake was Baker Hughes: 187,612 shares worth $6.83M. The largest sale was Regeneron Pharmaceuticals, an estimated $4.63M.
By sector, the portfolio is most concentrated in Industrials at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.
- Oliver Luxxe Assets's largest Q1 2022 buy was Baker Hughes: 187,612 shares worth $6.83M.
- Oliver Luxxe Assets added most to Procter & Gamble in Q1 2022, an estimated $4.59M increase.
- Oliver Luxxe Assets's biggest Q1 2022 reduction was iShares Core S&P Small-Cap ETF, cutting an estimated $2.03M.
- Oliver Luxxe Assets fully exited Regeneron Pharmaceuticals in Q1 2022, selling an estimated $4.63M.
- Oliver Luxxe Assets's ten largest holdings make up 22% of its $395M portfolio in Q1 2022.
- Oliver Luxxe Assets opened 31 new positions and closed 36 in Q1 2022.
- Oliver Luxxe Assets's portfolio value rose 0.05% quarter-over-quarter to $395M.
Based on Oliver Luxxe Assets's 13F filing for Q1 2022, filed 13 May 2022.